Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients.

Massa C, Karn T, Weber KE, Schneeweiss A, Hanusch C, Blohmer JU, Zahm DM, Jackisch C, van Mackelenbergh MT, Thomalla J, Marmé F, Huober J, Müller V, Schem C, Mueller A, Stickeler E, Biehl K, Fasching P, Untch M, Loibl S, Denkert C, Seliger B (2024)

Publication Type: Journal article, Letter

Publication year: 2024

Journal

Book Volume: 14

Journal Issue: 4

DOI: 10.1002/ctm2.1617

Authors with CRIS profile

Involved external institutions

Sana Klinikum Offenbach Germany (DE) Universitätsklinikum Gießen und Marburg (UKGM) Germany (DE) Martin-Luther-Universität Halle-Wittenberg (MLU) Germany (DE) Rotkreuzklinikum München Germany (DE) Universitätsklinikum Aachen (UKA) Germany (DE) SRH Wald-Klinikum Gera Germany (DE) Charité - Universitätsmedizin Berlin Germany (DE) Universitätsklinikum Mannheim Germany (DE) Goethe-Universität Frankfurt am Main Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) Germany (DE) Praxis für Hämatologie und Onkologie Koblenz Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) GBG Forschungs GmbH (German Breast Group) Germany (DE) Krankenhaus Jerusalem Germany (DE) HELIOS Kliniken Germany (DE) Kantonsspital St.Gallen Switzerland (CH) Universitätsklinikum Hamburg-Eppendorf (UKE) Germany (DE)

How to cite

APA:

Massa, C., Karn, T., Weber, K.E., Schneeweiss, A., Hanusch, C., Blohmer, J.-U.,... Seliger, B. (2024). Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. Clinical and Translational Medicine, 14(4). https://doi.org/10.1002/ctm2.1617

MLA:

Massa, Chiara, et al. "Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients." Clinical and Translational Medicine 14.4 (2024).

BibTeX: Download